Please send news to Bioconnex

 

>>December

AngioDynamics awarded HealthTrust PICC contract
Drug developer CEO says "halo effect" of New York funding competition is good for business
Next step for Integrated Liner Technologies: Pharmaceutical manufacturing
Drug developer spells out plan for spending $50 million

 

>>November

New $1 Million NIH Grant Enables Clinical Trials of Artificial Pancreas

AMRI stock declines following weak third quarter report

How a drug developer's fiscal report impacts hundreds of jobs in New York

Pharmacy college president works with academic, corporate leaders to broaden curriculum
Health care leaders to gather in Albany to discuss cancer treatment

 

>>October

French company bets $700 million on success of New York-based drug developer

AngioDynamics reports $629,000 in quarterly net income

 

>>September

Albany Medical Center professor receives $1.5 million grant

New York biotech industry growth ranks among highest in nation

Biotechnology leaders gather next week in Albany region

New York lures South Florida biotech company

Former FDA head says biotech business model 'is basically falling apart'

 

>>August

Calls for medical device tax repeal gain momentum after feds mess up

CEO of New York drug test maker outlines game plan to beat foreign competitors

Biotech firm Breonics moving to Watervliet Arsenal

Regeneron partners with California drug company

Siena College invests $3M in new science center

Pfizer paying $35 million for drug marketing settlement

Delcath losses reach $11 million for the first half of 2014

$800,000 Awarded for Neuroscience Research by SUNY Students and Faculty

Thomas D'Ambra joins board at Albany College of Pharmacy and Health Sciences

AMRI and Regeneron executives talk strategies for making money

Two drug development companies with 1,600 workers in Albany, New York area sustain momentum

UAlbany biologist receives $1.43 million for research on stem cells

Regeneron Pharmaceuticals still paying off big bucks for investors

 

>>July

New president of Albany College of Pharmacy and Health Sciences seeks input from industry leaders

Merck cutting 600 jobs

10 minutes with Dr. Allen Carl, a professor, surgeon and inventor

$100 million science center will be constructed at key location on Skidmore College campus

New York biomedical company Cognigen is acquired by California firm

Investors betting on AngioDynamics' success prior to earnings report

Delcath board takes 50 percent pay cut as New York medical device company seeks turnaround

Regeneron executive says company is 'fiercely independent' despite partnership

New research center coming to Albany Nanotech complex

Investors doubled their money after betting on Albany Molecular Research Inc. turnaround

 

>>June

American Bio Medica Corp. names CEO

Albany Medical College develops biotech accelerator

Medtronic will buy Covidien for $42.9 billion; HQ goes to Ireland

Albany, New York distributor awarded two state health care supply contracts

Specialty Silicone Products expansion targets pharmaceutical and biomedical research business

Albany, New York biotech leaders share tips to success

Lifeline for the life sciences industry: $10 million R&D facility will focus on attracting supply chain companies

Taconic appoints new chief executive officer

AMRI to acquire injectable drug maker for $110 million

 

>>May

Research funding grows at UAlbany, College of Nanoscale Science and Engineering

UAlbany RNA Institute pioneers technology for biomedical and pharmaceutical companies

Top cancer scientist visiting Albany Medical Center

Losses continue as Delcath works for federal approval for chemotherapy system

 

>>April

Regeneron funds $750K fellowship program for science, math and engineering teachers

Albany, NY drug-development company continues evolution

Albany Molecular Research Inc. is closing Syracuse plant, relocating some jobs to Albany region

Albany Med prize awarded for ground-breaking cell research

Rensselaer biotech firm lands $1.5 million federal grant

U.S. Supreme Court battle over Teva Pharmaceutical drug patent could shake up industry

Missing in Action: The Real Medical Home

 

>>March

Albany Molecular buys Wisconsin drug firm for $41 million

 

>>February

AMRI's new CEO looking to buy competitors

Back in black: Drug developer AMRI turns a profit

What a trade group says about Albany's bio/med scene

 

>>January

Drugmaker Novartis will close its New York plant

Regeneron, Bayer to co-develop Eylea combination treatment

$105 Million State-Initiated Collaboration Between the NY Genome Center and University at Buffalo Advances Medical Science in New York

 

2013 News >>